These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12646011)

  • 1. An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.
    Johnson BM; Charman WN; Porter CJ
    AAPS PharmSci; 2002; 4(4):E40. PubMed ID: 12646011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A.
    Johnson BM; Charman WN; Porter CJ
    Drug Metab Dispos; 2003 Sep; 31(9):1151-60. PubMed ID: 12920171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of P-glycoprotein efflux on enterocyte residence time and enterocyte-based metabolism of verapamil.
    Johnson BM; Charman WN; Porter CJ
    J Pharm Pharmacol; 2001 Dec; 53(12):1611-9. PubMed ID: 11804391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption barriers in the rat intestinal mucosa. 3: Effects of polyethoxylated solubilizing agents on drug permeation and metabolism.
    Mudra DR; Borchardt RT
    J Pharm Sci; 2010 Feb; 99(2):1016-27. PubMed ID: 19650119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of P-glycoprotein on the rat intestinal permeability and metabolism of the BDDCS class 1 drug verapamil.
    Estudante M; Maya M; Morais JG; Soveral G; Benet LZ
    Mol Pharm; 2013 Nov; 10(11):4038-45. PubMed ID: 24044638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
    Varma MV; Panchagnula R
    Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
    Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
    Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
    Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.
    Shen Q; Li W; Lin Y; Katsumi H; Okada N; Sakane T; Fujita T; Yamamoto A
    J Pharm Pharmacol; 2008 Dec; 60(12):1633-41. PubMed ID: 19000368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor.
    Iqbal J; Hombach J; Matuszczak B; Bernkop-Schnürch A
    J Control Release; 2010 Oct; 147(1):62-9. PubMed ID: 20603165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access.
    Collnot EM; Baldes C; Schaefer UF; Edgar KJ; Wempe MF; Lehr CM
    Mol Pharm; 2010 Jun; 7(3):642-51. PubMed ID: 20205474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies.
    Wandel C; Kim RB; Kajiji S; Guengerich P; Wilkinson GR; Wood AJ
    Cancer Res; 1999 Aug; 59(16):3944-8. PubMed ID: 10463589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model.
    Cummins CL; Salphati L; Reid MJ; Benet LZ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):306-14. PubMed ID: 12649383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor.
    Zhang Y; Guo X; Lin ET; Benet LZ
    Drug Metab Dispos; 1998 Apr; 26(4):360-6. PubMed ID: 9531525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.
    Wempe MF; Wright C; Little JL; Lightner JW; Large SE; Caflisch GB; Buchanan CM; Rice PJ; Wacher VJ; Ruble KM; Edgar KJ
    Int J Pharm; 2009 Mar; 370(1-2):93-102. PubMed ID: 19100824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein and surfactants: effect on intestinal talinolol absorption.
    Bogman K; Zysset Y; Degen L; Hopfgartner G; Gutmann H; Alsenz J; Drewe J
    Clin Pharmacol Ther; 2005 Jan; 77(1):24-32. PubMed ID: 15637528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kinetic evaluation of the absorption, efflux, and metabolism of verapamil in the autoperfused rat jejunum.
    Johnson BM; Chen W; Borchardt RT; Charman WN; Porter CJ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):151-8. PubMed ID: 12649363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
    Föger F; Hoyer H; Kafedjiiski K; Thaurer M; Bernkop-Schnürch A
    Biomaterials; 2006 Dec; 27(34):5855-60. PubMed ID: 16919723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cremophor-EL and polysorbate-80 on digoxin permeability across rat jejunum: delineation of thermodynamic and transporter related events using the reciprocal permeability approach.
    Katneni K; Charman SA; Porter CJ
    J Pharm Sci; 2007 Feb; 96(2):280-93. PubMed ID: 17051595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interferon-gamma on the pharmacokinetics of digoxin, a P-glycoprotein substrate, intravenously injected into the mouse.
    Kawaguchi H; Matsui Y; Watanabe Y; Takakura Y
    J Pharmacol Exp Ther; 2004 Jan; 308(1):91-6. PubMed ID: 14569074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.